Cargando…
COVID pandemic and denosumab adherence
Autores principales: | Minisola, S., Cipriani, C., Vigna, E., Sonato, C., Colangelo, L., Monti, F., Pepe, J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer London
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8783783/ https://www.ncbi.nlm.nih.gov/pubmed/35066593 http://dx.doi.org/10.1007/s00198-021-06274-x |
Ejemplares similares
-
Update on the safety and efficacy of teriparatide in the treatment of osteoporosis
por: Minisola, Salvatore, et al.
Publicado: (2019) -
Occipital bone and tumor-induced osteomalacia: a rare tumor site for an uncommon paraneoplastic syndrome
por: Colangelo, Luciano, et al.
Publicado: (2023) -
Denosumab and muscle performance
por: Rolvien, Tim, et al.
Publicado: (2022) -
Denosumab and osteonecrosis of the jaw
por: Bower, Robert
Publicado: (2019) -
Genetic aspects underlying the normocalcemic and hypercalcemic phenotypes of primary hyperparathyroidism
por: Viviani, Arianna, et al.
Publicado: (2023)